Q32 Bio (QTTB) Operating Expenses (2017 - 2026)

Q32 Bio's Operating Expenses history runs 10 years deep, the most recent figure standing at $7.7 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 36.85% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $32.3 million (down 49.08% YoY), while the FY2025 annual figure was $36.8 million, down 44.28% from the prior year.
• Operating Expenses was $7.7 million for Q1 2026 at Q32 Bio, down from $7.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $38.4 million in Q1 2022 to a low of $7.6 million in Q3 2025.
• Historically, Operating Expenses has averaged $17.0 million across 5 years, with a median of $12.2 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 73.14% in 2023, then surged 94.82% in 2024.
• A 5-year view of Operating Expenses shows it stood at $35.3 million in 2022, then sank by 68.42% to $11.1 million in 2023, then surged by 30.31% to $14.5 million in 2024, then tumbled by 45.9% to $7.9 million in 2025, then retreated by 1.73% to $7.7 million in 2026.
• The last three Operating Expenses figures came in at $7.7 million (Q1 2026), $7.9 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.